Merck
MRK
#38
Rank
S$471.29 B
Marketcap
S$191.03
Share price
2.18%
Change (1 day)
70.42%
Change (1 year)

EPS for Merck (MRK)

EPS in 2026 (TTM): S$1.63

According to Merck's latest financial reports the company's current EPS (TTM) is S$1.62. In 2025 the company made an earnings per share (EPS) of S$9.34 an increase over its 2024 EPS that were of S$8.64.

EPS history for Merck from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S$1.63-82.51%
2025S$9.348.15%
2024S$8.644308.46%
2023S$0.20-97.32%
2022S$7.3210.92%
2021S$6.6084.68%
2020S$3.57-27.2%
2019S$4.9163.44%
2018S$3.00151.11%
2017S$1.20-54.58%
2016S$2.6330.21%
2015S$2.02-61.99%
2014S$5.32180.51%
2013S$1.90-31.82%
2012S$2.786.62%
2011S$2.61

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$11.16 590.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$8.51 426.26%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$0.97-39.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$3.98 146.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$38.18 2,261.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$20.72 1,181.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$2.43 50.37%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
S$5.80 258.74%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$4.09 152.67%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
S$0.80-50.22%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel